(Q33352047)

26 July 2017

title

Selecting dose-intense drug combinations: metastatic breast cancer (English)

1 reference

26 July 2017

main subject

metastatic breast cancer

1 reference

modelling biological systems

inferred from title

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1349245

16 September 2022

author name string

E. L. Korn

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1349245

16 September 2022

R. Simon

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1349245

16 September 2022

language of work or name

English

0 references

publication date

1 March 1992

1 reference

Breast Cancer Research and Treatment

26 July 2017

published in

1 reference

26 July 2017

volume

20

1 reference

26 July 2017

issue

3

1 reference

26 July 2017

page(s)

155-166

1 reference

High dose cyclophosphamide therapy in solid tumors: Therapeutic, toxic, and immunosuppressive effects

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF01834621

The use of granulocyte colony-stimulating factor to increase the intensity of treatment with doxorubicin in patients with advanced breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01834621

Advanced breast cancer: high-dose chemotherapy and bone marrow autotransplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01834621

Evaluation of cyclophosphamide dosage schedules in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01834621

Dose-response in the treatment of breast cancer: a critical review

21 January 2018

1 reference

12 December 2020

High-dose cyclophosphamide (NSC-26271) for recurrent or progressive ovarian adenocarcinoma

1 reference

12 December 2020

Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma

1 reference

12 December 2020

Intensive cyclophosphamide (NSC-26271) therapy for solid tumors

1 reference

12 December 2020

A phase I-II study of bialkylator chemotherapy, high-dose thiotepa, and cyclophosphamide with autologous bone marrow reinfusion in patients with advanced cancer

1 reference

12 December 2020

High-dose carboplatin in refractory ovarian cancer patients.

1 reference

12 December 2020

High-dose cisplatin in hypertonic saline: reduced toxicity of a modified dose schedule and correlation with plasma pharmacokinetics. A Northern California Oncology Group Pilot Study in non-small-cell lung cancer

1 reference

12 December 2020

Phase I trial of escalating doses of cisplatin in hypertonic saline

1 reference

12 December 2020

Phase I and pharmacodynamic study of taxol in refractory acute leukemias.

1 reference

12 December 2020

High-dose cisplatin in hypertonic saline in refractory ovarian cancer

1 reference

12 December 2020

The importance of dose intensity in chemotherapy of metastatic breast cancer

1 reference

12 December 2020

High-dose i.v. thiotepa and cryopreserved autologous bone marrow transplantation for therapy of refractory cancer

1 reference

12 December 2020

Keeping an open mind about the doses of chemotherapy

1 reference

12 December 2020

High-dose cyclophosphamide in the treatment of refractory lymphomas and solid tumor malignancies

1 reference

12 December 2020

Phase I trial of taxol given as a 24-hour infusion every 21 days: responses observed in metastatic melanoma.

1 reference

12 December 2020

Selecting drug combinations based on total equivalent dose (dose intensity)

1 reference

12 December 2020

High-dose cyclophosphamide with autologous marrow transplantation for small cell carcinoma of the bronchus

1 reference

12 December 2020

A randomized trial of two dose levels of cyclophosphamide, methotrexate, and fluorouracil chemotherapy for patients with metastatic breast cancer.

1 reference

12 December 2020

A phase I clinical and pharmacokinetic study of carboplatin and autologous bone marrow support

1 reference

12 December 2020

A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study

1 reference

12 December 2020

The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. Gastrointestinal Tumor Study Group

1 reference

12 December 2020

Bone marrow autotransplantation for solid tumors--prospects

1 reference

12 December 2020

Cardiotoxicity Associated With High-Dose Cyclophosphamide Therapy

1 reference

12 December 2020

A phase I-II study of cyclophosphamide, thiotepa, and carboplatin with autologous bone marrow transplantation in solid tumor patients

1 reference

12 December 2020

Proceedings: Evaluation of combination vs. sequential cytotoxic chemotherapy in the treatment of advanced breast cancer

1 reference

12 December 2020

High-dose cisplatin with sodium thiosulfate protection.

1 reference

12 December 2020

Cisplatin as first-line therapy for metastatic breast cancer

1 reference

12 December 2020

Phase II clinical trial of cis-dichlorodiammine platinum (cis-DDP) for antitumorigenic activity in previously untreated patients with metastatic breast cancer

1 reference

12 December 2020

Dose: a critical factor in cancer chemotherapy

1 reference

12 December 2020

Treatment of patients with advanced colorectal carcinomas with fluorouracil alone, high-dose leucovorin plus fluorouracil, or sequential methotrexate, fluorouracil, and leucovorin: a randomized trial of the Northern California Oncology Group

1 reference

12 December 2020

High-dose cyclophosphamide in small-cell carcinoma of the lung

1 reference

12 December 2020

Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01834621

1 reference

Dimensions Publication ID

26 July 2017

1037117461

0 references

1 reference